Vaibhav Patil

Vaibhav Patil

Auto-generated profile, based on publicly available information

Vaibhav Patil

Centre for Research in Medical Devices (CÚRAM), National University of Ireland, Galway H91 W2TY, Ireland

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 March 2014 in Journal of Drug Delivery
Verified
Journal Article
Open access
PDF file
MTMukeshchand Thakur
Mukeshchand Thakur
SPSunil Pandey
Sunil Pandey
AMAshmi Mewada
Ashmi Mewada
VPVaibhav Patil
Vaibhav Patil
MKMonika Khade
Monika Khade
MSMadhuri Sharon
Madhuri Sharon
A novel report on microwave assisted synthesis of bright carbon dots (C-dots) using gum arabic (GA) and its use as molecular vehicle to ferry ciprofloxacin hydrochloride, a broad spectrum antibiotic, is reported in the present work. Density gradient centrifugation (DGC) was used to separate different types of C-dots. After careful analysis of the fractions obtained after centrifugation, ciprofloxacin was attached to synthesize ciprofloxacin conjugated with C-dots (Cipro@C-dots conjugate). Release of ciprofloxacin was found to be extremely regulated under physiological conditions. Cipro@C-dots were found to be biocompatible on Vero cells as compared to free ciprofloxacin (1.2 mM) even at very high concentrations. Bare C-dots (∼13 mg mL−1) were used for microbial imaging of the simplest eukaryotic model—Saccharomyces cerevisiae (yeast). Bright green fluorescent was obtained when live imaging was performed to view yeast cells under fluorescent microscope suggesting C-dots incorporation inside the cells. Cipro@C-dots conjugate also showed enhanced antimicrobial activity against both model gram positive and gram negative microorganisms. Thus, the Cipro@C-dots conjugate paves not only a way for bioimaging but also an efficient new nanocarrier for controlled drug release with high antimicrobial activity, thereby serving potential tool for theranostics.

1 February 2018 in Acta Biomaterialia
Verified
Journal Article
Closed access
Aitor LarrañagaAitor Larrañaga
Aitor Larrañaga
IIIsma Liza Mohd Isa
Isma Liza Mohd Isa
VPVaibhav Patil
Vaibhav Patil
STSagana Thamboo
Sagana Thamboo
MLMihai Lomora
Mihai Lomora
Abhay PanditAbhay Pandit
Abhay Pandit

12 February 2019 in ACS Omega
Verified
Journal Article
Open access
MKMichelle Kilcoyne
Michelle Kilcoyne
VPVaibhav Patil
Vaibhav Patil
COClaire O’grady
Claire O’grady
CBCiara Bradley
Ciara Bradley
SMSiobhan McMahon
Siobhan McMahon
Glycosylation is ubiquitous throughout the central nervous system and altered following spinal cord injury (SCI). The glial scar that forms following SCI is composed of several chondroitin sulfate proteoglycans, which inhibit axonal regrowth. Cyclosporin-A (CsA), an immunosuppressive therapeutic, has been proposed as a potential treatment after SCI. We investigated CsA treatment in the spinal cord of healthy, contusion injured, and injured CsA-treated rats. Lectin histochemistry using fluorescently labeled lectins, SBA, MAA, SNA-I, and WFA, was performed to identify the terminal carbohydrate residues of glycoconjugates within the spinal cord. SBA staining decreased in gray and white matter following spinal cord injury, whereas staining was increased at the lesion site in CsA-treated animals, indicating an increase in galactose and N-acetylgalactosamine terminal structures. No significant changes in MAA were observed. WFA staining was abundant in gray matter and observed to increase at the lesion site, in agreement with increased expression of chondroitin sulfate proteoglycans. SNA-I-stained blood vessels in all spinal cord regions and dual staining identified a subpopulation of astrocytes in the lesion site, which expressed α-(2,6)-sialic acid. Glycosylation were altered in injured spinal cord treated with CsA, indicating that glycosylation and alteration of particular carbohydrate structures are important factors to consider in the examination of the environment of the spinal cord after injury.